PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM)

CUSIP: 74449F209

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Shares, without par value
Shares outstanding
4,527,832
Total 13F shares
455,006
Share change
-294,864
Total reported value
$272,834
Price per share
$0.60
Number of holders
8
Value change
-$1,162,584
Number of buys
8
Number of sells
7

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 74449F209?
CUSIP 74449F209 identifies PBM - PSYENCE BIOMEDICAL LTD. - Common Shares, without par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PBM - PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Hudson Bay Capital Management LP
13F 13D/G
Company
5%
from 13D/G
380,000
$743,670 31 Dec 2024
Harraden Circle Investments, LLC
13F
Company
mixed-class rows
1,332,323
mixed-class rows
$401,262 31 Dec 2024
13F
Psyence Group Inc.
13D/G
15%
678,722
$380,084 $0 25 Mar 2025
Essential Planning, LLC.
13F
Company
1.6%
73,278
$162,605 31 Dec 2024
13F
AdvisorShares Investments LLC
13F
Company
0.59%
26,923
$56,808 31 Dec 2024
13F
HRT FINANCIAL LP
13F
Company
0.58%
26,127
$55,000 31 Dec 2024
13F
Virtu Financial LLC
13F
Company
mixed-class rows
63,243
mixed-class rows
$28,000 31 Dec 2024
13F
UBS Group AG
13F
Company
0.28%
12,712
$26,822 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.25%
11,490
$24,244 31 Dec 2024
13F
Scientech Research LLC
13F
Company
0.25%
11,183
$23,596 31 Dec 2024
13F
Connective Capital Management, LLC
13F
Company
0.25%
11,149
$23,524 31 Dec 2024
13F
AdvisorShares Trust
13D/G
0.79%
26,924
$15,077 $0 31 Dec 2024
Polar Asset Management Partners Inc.
13F
Company
class O/S missing
733,000
$10,555 31 Dec 2024
13F
MMCAP International Inc. SPC
13F
Company
class O/S missing
600,000
$8,640 31 Dec 2024
13F
Calamos Advisors LLC
13F
Company
class O/S missing
500,000
$6,150 31 Dec 2024
13F
CANTOR FITZGERALD, L. P.
13F
Individual
class O/S missing
468,500
$5,622 31 Dec 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.04%
1,993
$4,205 31 Dec 2024
13F
Saba Capital Management, L.P.
13F
Company
class O/S missing
297,847
$4,140 31 Dec 2024
13F
ARISTEIA CAPITAL, L.L.C.
13F
Company
class O/S missing
272,857
$3,793 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
class O/S missing
200,117
$2,882 31 Dec 2024
13F
LMR Partners LLP
13F
Company
class O/S missing
200,000
$2,880 31 Dec 2024
13F
PERISCOPE CAPITAL INC.
13F
Company
class O/S missing
200,000
$2,880 31 Dec 2024
13F
CLEAR STREET LLC
13F
Company
class O/S missing
180,566
$2,600 31 Dec 2024
13F
TENOR CAPITAL MANAGEMENT Co., L.P.
13F
Company
class O/S missing
150,000
$2,160 31 Dec 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
class O/S missing
175,352
$2,157 31 Dec 2024
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
class O/S missing
147,101
$2,118 31 Dec 2024
13F
Clear Street Derivatives LLC
13F
Company
class O/S missing
109,356
$1,575 31 Dec 2024
13F
Westchester Capital Management, LLC
13F
Company
class O/S missing
92,073
$1,132 31 Dec 2024
13F
Yakira Capital Management, Inc.
13F
Company
class O/S missing
76,843
$1,107 31 Dec 2024
13F
Mint Tower Capital Management B.V.
13F
Company
class O/S missing
50,000
$1,000 31 Dec 2024
13F
Walleye Trading LLC
13F
Company
class O/S missing
44,080
$635 31 Dec 2024
13F
Walleye Capital LLC
13F
Company
class O/S missing
34,282
$494 31 Dec 2024
13F
Ancora Advisors LLC
13F
Company
class O/S missing
5,000
$72 31 Dec 2024
13F

Institutional Holders of PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) as of Q1 2025

As of 31 Mar 2025, PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 455,006 shares. The largest 8 holders included SABBY MANAGEMENT, LLC, CITADEL ADVISORS LLC, Virtu Financial LLC, AdvisorShares Investments LLC, UBS Group AG, TWO SIGMA SECURITIES, LLC, Stonehage Fleming Financial Services Holdings Ltd, and MORGAN STANLEY. This page lists 8 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
11
Q1 2025 holders
8
Holder diff
-3
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.